|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Changing relationships in public open space and pri- vate open space in suburbs in south - western Australia 显示文摘 | Grose M J | 2009 | Landscape and urban planning2009，，1： | 1 |
| 2 | The contribution of element carbon to the optical properties of rural atmospheric aerosols 显示文摘 | Japar S M Brachaczek W W Grose R A | 1986 | Atmospheric Environment1986，20，： | 1 |
| 3 | Open reduction and internal fxation of tibial pilon fractures using a lateral approach 显示文摘 | Grose A Gardner M J Hettrich C | 2007 | J Orthop Trauma2007，21，8： | 1 |
| 4 | Hemodynamic and hormonal changes during erythropoietin therapy in hemodialysis patients显示文摘 | Kingma I Grose JH | 1998 | J Am Soc Nephrol1998，9，2： | 1 |
| 5 | Silicalite,a new hydrophobic crystalline silica molecular sieve显示文摘 | FLANIGENE M BENNETT J M GROSE R W | 1978 | Nature1978，271，： | 1 |
| 6 | Possibilities and limitations for quantitative precipitation forecasts using nowcasting methods with infrared geosynchronous satellite imagery显示文摘 | Grose A M E Smith E A Chung H-S | 2002 | J Appl Metero2002，41，： | 1 |
| 7 | Open reduction and internal fixation of tibial pilon fractures using a later- al approach显示文摘 | Grose A Gardner M J Hettrich C | 2007 | J Orthop Trauma2007，21，： | 1 |
| 8 | Plasma and peritoneal显示文摘 | Lebel M Moreau V Grose JH | 2002 | Clin Nephrol2002，49，5： | 1 |
| 9 | Silicalite, a new hydrophobic crystalline silica molecular sieve显示文摘 | FLANIGEN E M BENNETT J M GROSE R W COHEN J P PATTON R L KIRCHNER R M | 1978 | Nature1978，271，： | 1 |
| 10 | Hemodynamic and hormonalchanges during erythropoietin therapy in hemodialysis patients显示文摘 | Kingma I Grose JH | 1998 | J Am Soc Nephrol1998，9，1： | 1 |
| 11 | Signatures of Molecular Magnetism in Single-Molecule Transport Spectroscopy显示文摘 | Jo M H Grose J E Baheti K | 2006 | Nano Lett2006，6，： | 1 |
| 12 | Silicalite,a new hydrophobic crystalline silica molecular sieve显示文摘 | Flanigen E M Bennett J M Grose R W | 1978 | Nature1978，271，9： | 1 |
| 13 | Sili- calite a New Hydrophobic Crystalline Silica Molecu- lar-sieve显示文摘 | Flanigen E M Bennett J M Grose R W | 1978 | Nature1978，271，： | 1 |
| 14 | Hemodynamic and hormonal changes during erythropoietin therapy in hemodialysis patients显示文摘 | Lebel M Kingma I Grose JH | 1998 | JAm Soc Nephrol1998，9，1： | 1 |
| 15 | Captopril suppression versus salt loading in confirming primary aldosteronism 显示文摘 | Agharazii M Douville P Grose JH | 2001 | Hypertension2001，37，6： | 1 |
| 16 | Multi- frequency tympanometry and evoked otoacoustic emis- sions in neonates during the first 24 hours of life显示文摘 | MCKINLEY A M GROSE J H ROUSH J | 1997 | J Am Acad Audiol1997，8，： | 1 |
| 17 | Open ruduction and internal fixation oftibial pilon fractures using a lateral approach 显示文摘 | Grose A Gardner M J Hettrich C | 2007 | J Orthop Trauma2007，21，8： | 1 |
| 18 | Open reduction and internal fixation of tibial pilon fractures using a lateral approach显示文摘 | GROSE A GARDNER M J HETTRICH C | 2007 | J Orthop Trauma2007，21，8： | 1 |
| 19 | Pancreatic cancer organotypics: High throughput, preclinical models for pharmacological agent evaluation显示文摘Pancreatic cancer carries a terrible prognosis,as the fourth most common cause of cancer death in the Western world.There is clearly a need for new therapies to treat this disease.One of the reasons no effective treatment has been developed in the past decade may in part,be explained by the diverse influences exerted by the tumour microenvironment.The tumour stroma cross-talk in pancreatic cancer can influence chemotherapy delivery and response rate.Thus,appropriate preclinical in vitro models which can bridge simple 2D in vitro cell based assays and complex in vivo models are required to understand the biology of pancreatic cancer.Here we discuss the evolution of 3D organotypic models,which recapitulare the morphological and functional features of pancreatic ductal adenocarcinoma(PDAC).Organotypic cultures are a valid high throughput preclinical in vitro model that maybe a useful tool to help establish new therapies for PDAC.A huge advantage of the organotypic model system is that any component of the model can be easily modulated in a short timeframe.This allows new therapies that can target the cancer,the stromal compartment or both to be tested in a model that mirrors the in vivo situation.A major challenge for the future is to expand the cellular composition of the organotypic model to further develop a system that mimics the PDAC environment more precisely.We discuss how this challenge is being met to increase our understanding of this terrible disease and develop novel therapies that can improve the prognosis for patients. | Stacey J Coleman Jennifer Watt Prabhu Arumugam Leonardo Solaini Elisabeta Carapuca Mohammed Ghallab Richard P Grose Hemant M Kocher | 2014 | World Journal of Gastroenterology2014，20，26： | 1 |
| 20 | Silicalite, a new hydrophobic crystalline silica molecular sieve显示文摘 | Flanigen E M Bennett J M Grose R W | 1978 | Nature1978，271，9： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员